CD274 and neoplasm: Nevertheless, evaluating the sensitivity or resistance to target therapeutic populations according to stratification by cancer markers including TMB, PD-L1, tumor-infiltrating lymphocytes, and neoantigens can enhance the predictive efficacy of immunotherapeutic response [38].